PETER J GRAHAM
CIK 1235635 · Chief Legal Officer · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$917.4K
Companies
4
Total Filings
32
Lifetime Open-Market Net
-$206.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADCT | Chief Legal Officer | 841,640 | $1.09 | $917.4K | $0 | 5 | 2026-07-02 |
| ANTARES PHARMA, INC. (ATRS) Delisted | EVP General Counsel, Secretary | 630,244 | $5.59 | $3.52M | -$206.2K | 20 | 2022-03-04 |
| DCTH | EVP; General Counsel | 0 | $11.56 | $0 | $0 | 5 | 2013-11-18 |
| E-Z-EM, Inc. (EZEM) Delisted | SVP - Chief Legal Officer | 0 | — | — | $0 | 1 | 2008-04-02 |
Recent Filings · Page 3 of 4
32 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-05 | ANTARES PHARMA, INC. (ATRS) Delisted | Tax (F) | −15,422 | -$41.5K | EDGAR |
| 2017-06-09 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +84,801 | $227.1K | EDGAR |
| 2016-06-06 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | +121,050 | $135.6K | EDGAR |
| 2016-03-23 | ANTARES PHARMA, INC. (ATRS) Delisted | Buy (P) | +20,000 | $15.4K | EDGAR |
| 2015-07-22 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-07-16 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-11-18 | DCTH | Grant (A) | — | $0 | EDGAR |
| 2013-03-13 | DCTH | Grant (A) | — | $0 | EDGAR |
| 2012-03-01 | DCTH | Grant (A) | +9,000 | $0 | EDGAR |
| 2011-03-11 | DCTH | Grant (A) | +6,000 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.